Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX was delisted on the 22nd of January, 2024.
58 hedge funds and large institutions have $319M invested in Mirati Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 7 reducing their positions, and 4 closing their positions.
350% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 4
300% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 7
113% more capital invested
Capital invested by funds: $150M → $319M (+$169M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
32% more funds holding
Funds holding: 44 → 58 (+14)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.1M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$9.97M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$7.53M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$3.52M |
| 5 |
BC
Broadfin Capital
New York
|
+$2.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$1.19M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$927K |
| 3 |
Goldman Sachs
New York
|
-$506K |
| 4 |
Morgan Stanley
New York
|
-$420K |
| 5 |
JP Morgan Chase
New York
|
-$81.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Federated Hermes
Pittsburgh,
Pennsylvania
| $9K | +$7.41K | +316 | New |
|
52
Barclays
London,
United Kingdom
| $7K | -$7.55K | -322 | -55% |
|
53
BlackRock
New York
| $7K | +$5.58K | +238 | New |
|
|
FA
54
Financial Advantage
Columbia,
Maryland
| $6K | +$4.69K | +200 | New |
|
55
BNP Paribas Financial Markets
Paris,
France
| $5.8K | +$4.64K | +198 | New |
|
|
BRWM
56
B. Riley Wealth Management
Memphis,
Tennessee
| $2K | – | – | – |
|
57
Bank of America
Charlotte,
North Carolina
| $1K | +$516 | +22 | New |
|
58
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $162 | +$58.1K | +2,476 | +80% |
|
|
59
Goldman Sachs
New York
| – | -$506K | -27,295 | Closed |
|
|
TRCT
60
Tower Research Capital (TRC)
New York
| – | -$38K | -2,059 | Closed |
|
61
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$7K | -400 | Closed |
|
62
Creative Planning
Overland Park,
Kansas
| – | -$5K | -258 | Closed |
|
MRTX Hedge Fund Activity: Q1 2015 in Review
58 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Mirati Therapeutics, Inc. Common Stock (MRTX) for Q1 2015, worth a combined $319M — up 113% from $150M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new MRTX positions and 4 closed out — a net gain of 14 holders — while 28 added to existing stakes and 7 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $26.1M. The largest seller was QVT Financial, cutting an estimated $1.19M.
- 58 institutional investors held Mirati Therapeutics, Inc. Common Stock (MRTX) as of Q1 2015, up from 44 in Q4 2014.
- Funds reported $319M of Mirati Therapeutics, Inc. Common Stock stock for Q1 2015, up 113% quarter-over-quarter.
- 18 funds opened new Mirati Therapeutics, Inc. Common Stock positions in Q1 2015 and 4 closed out, a net change of +14 holders.
- The largest Mirati Therapeutics, Inc. Common Stock buyer in Q1 2015 was Fidelity Investments, an estimated $26.1M added.
- The largest Mirati Therapeutics, Inc. Common Stock seller in Q1 2015 was QVT Financial, an estimated $1.19M sold.
Based on aggregated 13F filings for Q1 2015.